ATE49233T1 - Vektoren zur transformation von hefe. - Google Patents
Vektoren zur transformation von hefe.Info
- Publication number
- ATE49233T1 ATE49233T1 AT84104456T AT84104456T ATE49233T1 AT E49233 T1 ATE49233 T1 AT E49233T1 AT 84104456 T AT84104456 T AT 84104456T AT 84104456 T AT84104456 T AT 84104456T AT E49233 T1 ATE49233 T1 AT E49233T1
- Authority
- AT
- Austria
- Prior art keywords
- yeast
- polypeptides
- exogenous
- endorphin
- secretion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/675—Beta-endorphins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48775383A | 1983-04-22 | 1983-04-22 | |
EP84104456A EP0123294B1 (de) | 1983-04-22 | 1984-04-19 | Vektoren zur Transformation von Hefe |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE49233T1 true ATE49233T1 (de) | 1990-01-15 |
Family
ID=23936984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT84104456T ATE49233T1 (de) | 1983-04-22 | 1984-04-19 | Vektoren zur transformation von hefe. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0123294B1 (de) |
JP (1) | JPS60501140A (de) |
AT (1) | ATE49233T1 (de) |
DE (1) | DE3480939D1 (de) |
IL (1) | IL71615A0 (de) |
WO (1) | WO1984004330A1 (de) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7198919B1 (en) | 1983-04-25 | 2007-04-03 | Genentech, Inc. | Use of alpha factor sequences in yeast expression systems |
ATE95236T1 (de) * | 1983-04-25 | 1993-10-15 | Chiron Corp | Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren. |
NZ207926A (en) * | 1983-04-25 | 1988-04-29 | Genentech Inc | Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast |
IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
US4870008A (en) * | 1983-08-12 | 1989-09-26 | Chiron Corporation | Secretory expression in eukaryotes |
KR850004274A (ko) * | 1983-12-13 | 1985-07-11 | 원본미기재 | 에리트로포이에틴의 제조방법 |
NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
DE3581722D1 (de) * | 1984-07-20 | 1991-03-14 | Celltech Ltd | Eukaryotische expressionsvektoren. |
GB2177095B (en) * | 1984-07-20 | 1988-05-25 | Celltech Ltd | Eucaryotic expression vectors |
US5187263A (en) * | 1984-10-12 | 1993-02-16 | Zymogenetics, Inc. | Expression of biologically active PDGE analogs in eucaryotic cells |
EP0487116B1 (de) * | 1984-10-12 | 1999-12-29 | ZymoGenetics, Inc. | Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen |
US5498600A (en) * | 1984-10-12 | 1996-03-12 | Zymogenetics, Inc. | Biologically active mosaic proteins |
US5045633A (en) * | 1985-02-25 | 1991-09-03 | Zymogenetics, Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
FR2593518B1 (fr) * | 1985-05-02 | 1989-09-08 | Transgene Sa | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
US5821079A (en) * | 1985-05-02 | 1998-10-13 | Transgene S.A. | Vectors for the expression and secretion of hirudin by transformed yeasts |
US4935350A (en) * | 1985-11-18 | 1990-06-19 | Amgen | Materials and methods for controlling plasmid copy number and stability |
GB8530631D0 (en) | 1985-12-12 | 1986-01-22 | Ciba Geigy Ag | Thrombin inhibitors |
MY101203A (en) * | 1985-12-12 | 1991-08-17 | Ucp Gen Pharma Ag | Production of thrombin iinhibitors. |
US5024941A (en) * | 1985-12-18 | 1991-06-18 | Biotechnica International, Inc. | Expression and secretion vector for yeast containing a glucoamylase signal sequence |
EP0234871A3 (de) * | 1986-02-28 | 1988-10-12 | Merck & Co. Inc. | Regulierbare Expression rekombinanter Proteine in Hefe |
EP0234862A3 (de) * | 1986-02-28 | 1988-10-05 | Merck & Co. Inc. | Expression rekombinanter Proteine in Hefe |
FR2599755B1 (fr) * | 1986-06-10 | 1990-04-20 | Transgene Sa | Bloc d'expression d'une amyloglucosidase dans une levure, levure transformee et procede de preparation d'enzyme |
DK293787A (da) * | 1986-06-10 | 1987-12-11 | Transgene Sa | Ekspression af en amyloglucosidase |
IT1196484B (it) * | 1986-07-11 | 1988-11-16 | Sclavo Spa | Vettore ad espressione e secrezione in lieviti,utile per la preparazione di proteine eterologhe |
CA1340772C (en) | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
US5037743A (en) * | 1988-08-05 | 1991-08-06 | Zymogenetics, Inc. | BAR1 secretion signal |
DK105489D0 (da) * | 1989-03-03 | 1989-03-03 | Novo Nordisk As | Polypeptid |
FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
DE4309333A1 (de) * | 1993-03-17 | 1994-09-22 | Silica Gel Gmbh | Superparamagnetische Teilchen, Verfahren zu ihrer Herstellung und Verwendung derselben |
US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
CN1182451A (zh) | 1995-03-17 | 1998-05-20 | 诺沃挪第克公司 | 新的内切葡聚糖酶 |
GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
WO1997031943A1 (en) | 1996-03-01 | 1997-09-04 | Novo Nordisk A/S | Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
US6946134B1 (en) | 2000-04-12 | 2005-09-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
AU2001266557A1 (en) | 2000-04-12 | 2001-10-23 | Human Genome Sciences, Inc. | Albumin fusion proteins |
BR0208203A (pt) | 2001-03-22 | 2005-04-19 | Novo Nordisk Healthcare Ag | Polipeptìdeo do fator vii, derivado do fator vii, composição, composição farmacêutica, construção de polinucleotìdeo, célula hospedeira eucariótica, animal transgênico, planta transgênica, e, métodos para produzir o polipeptìdeo do fator vii e um derivado do fator vii, uso de um derivado do fator vii, métodos para o tratamento de episódios de hemorragia ou distúrbios de hemorragia em um paciente ou para a intensificação do sistema hemostático normal e para inibir a formação de trobo em um paciente |
US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
EP1432794B1 (de) | 2001-09-27 | 2011-11-09 | Novo Nordisk Health Care AG | Menschliche gerinnungsfaktor-vii-polypeptide |
WO2003060071A2 (en) | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7309505B2 (en) | 2002-09-13 | 2007-12-18 | Cornell Research Foundation, Inc. | Using mutations to improve Aspergillus phytases |
CN101870729A (zh) | 2003-09-09 | 2010-10-27 | 诺和诺德医疗保健公司 | 凝固因子ⅶ多肽 |
DK1713930T3 (da) | 2004-01-17 | 2011-01-17 | Korea Res Inst Of Bioscience | Hurtig screeningsmetode for translationsfusionspartnere til fremstilling af rekombinante proteiner og translationsfusionspartnere screenet derfra |
RU2412199C2 (ru) | 2005-04-18 | 2011-02-20 | Ново Нордиск А/С | Варианты ил-21 |
EP1907562A2 (de) * | 2005-07-25 | 2008-04-09 | The GI Company, Inc | Hefeexpressionsvektoren zur itf-herstellung |
WO2007031559A2 (en) | 2005-09-14 | 2007-03-22 | Novo Nordisk Health Care Ag | Human coagulation factor vii polypeptides |
US20120107267A1 (en) | 2009-03-11 | 2012-05-03 | Novo Nordisk A/S | Interleukin-21 variants having antagonistic binding to the il-21 receptor |
CN102712687A (zh) | 2009-07-17 | 2012-10-03 | 丹麦国家医院 | 作为补体激活的抑制剂的masp同种型 |
WO2011067283A1 (en) | 2009-12-01 | 2011-06-09 | Novo Nordisk A/S | Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases |
EP3815708A1 (de) | 2010-03-05 | 2021-05-05 | Omeros Corporation | Chimäre inhibitormoleküle mit komplementaktivierung |
PL2812024T3 (pl) | 2012-02-09 | 2018-09-28 | Var2 Pharmaceuticals Aps | Celowanie glikanów siarczanu chondroityny |
WO2014060401A1 (en) | 2012-10-15 | 2014-04-24 | Novo Nordisk Health Care Ag | Coagulation factor vii polypeptides |
EA037848B1 (ru) | 2016-07-14 | 2021-05-27 | Общество С Ограниченной Ответственностью "Биохимический Агент" | Гибридный белок, полинуклеотид, генетическая конструкция, продуцент, препарат для регенерации хряща (варианты) |
US20210278406A1 (en) | 2018-07-13 | 2021-09-09 | Varct Diagnostic Aps | Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa |
WO2022049409A1 (en) | 2020-09-02 | 2022-03-10 | Sia Terragen | Express diagnosticum for sars-cov-2 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4411994A (en) * | 1978-06-08 | 1983-10-25 | The President And Fellows Of Harvard College | Protein synthesis |
US4430428A (en) * | 1980-02-05 | 1984-02-07 | The Upjohn Company | Composition of matter and process |
US4443539A (en) * | 1980-02-05 | 1984-04-17 | The Upjohn Company | Process for preparing bovine growth hormone |
US4350764A (en) * | 1980-03-10 | 1982-09-21 | The Regents Of The University Of California | Microbiological synthesis of beta endorphin |
NZ199722A (en) * | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
US4615974A (en) * | 1981-08-25 | 1986-10-07 | Celltech Limited | Yeast expression vectors |
DE3382547D1 (de) * | 1983-01-12 | 1992-05-27 | Chiron Corp | Sekretorische expression in eukaryoten. |
-
1984
- 1984-04-18 JP JP59501817A patent/JPS60501140A/ja active Pending
- 1984-04-18 WO PCT/US1984/000601 patent/WO1984004330A1/en unknown
- 1984-04-19 DE DE8484104456T patent/DE3480939D1/de not_active Expired - Fee Related
- 1984-04-19 AT AT84104456T patent/ATE49233T1/de not_active IP Right Cessation
- 1984-04-19 EP EP84104456A patent/EP0123294B1/de not_active Expired - Lifetime
- 1984-04-22 IL IL71615A patent/IL71615A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE3480939D1 (de) | 1990-02-08 |
EP0123294A1 (de) | 1984-10-31 |
IL71615A0 (en) | 1984-07-31 |
EP0123294B1 (de) | 1990-01-03 |
WO1984004330A1 (en) | 1984-11-08 |
JPS60501140A (ja) | 1985-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE49233T1 (de) | Vektoren zur transformation von hefe. | |
FI102075B1 (fi) | Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit | |
ATE80660T1 (de) | Verfahren zur herstellung eines polypeptides. | |
IL94183A (en) | cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE | |
ATE133681T1 (de) | Mykobakterielle rekombinanten und peptide | |
ATE182901T1 (de) | Für androgen-rezeptor-protein kodierende dna | |
ES8306324A1 (es) | "proceso para la produccion microbiana de interferon fibroblasto humano". | |
EP0293443A4 (de) | Herstellung synthetischer dns und deren verwendung bei der synthese grosser polypeptide. | |
NO308310B1 (no) | Hovedsakelig rent KGF protein og dets anvendelse | |
ES8506347A1 (es) | Un metodo para producir un polipeptido de tipo il-2-". | |
IL80451A0 (en) | Dna sequences,recombinant dna molecules,processes for producing mis-like polypeptides and pharmaceutical containing said peptides | |
ATE250133T1 (de) | Verktorvermittelte genominsertion und expression von dna in bcg | |
NZ238056A (en) | Surface protein of metastasis forming tumour cells, related polypeptides, dna encoding these, antibodies, assays and pharmaceuticals | |
IL88151A (en) | Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it | |
DK611386A (da) | Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden | |
ATE142264T1 (de) | Rekombinante herstellung von a-ketten- polypeptiden von pdgf | |
IL84700A0 (en) | Hybrid proteins,dnas coding therefor,hybrid vectors containing such dnas and hosts transformed therewith,the preparation of such hybrid proteins and pharmaceutical compositions containing them | |
ES8704207A1 (es) | Procedimiento para preparar una molecula de adn | |
AU7873798A (en) | N-terminally extended proteins expressed in yeast | |
ES8802441A1 (es) | Procedimiento para preparar laminina humana | |
AU1541395A (en) | Folding proteins | |
ATE79651T1 (de) | Rekombinante materialien und verfahren zur herstellung von menschliche konnektive gewebe aktivierende peptide iii und deren analoge. | |
DE3485883D1 (de) | Rekombinante materialien und verfahren zur herstellung von menschliche konnektive gewebe aktivierende peptide iii und deren analoge. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |